Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides

A. M. Zeidan, M. A. Sekeres, G. Garcia-Manero, D. P. Steensma, K. Zell, J. Barnard, N. A. Ali, C. Zimmerman, G. Roboz, A. DeZern, A. Nazha, E. Jabbour, H. Kantarjian, S. D. Gore, J. P. Maciejewski, A. List, R. Komrokji

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides'. Together they form a unique fingerprint.

Medicine & Life Sciences